Magellan Diagnostics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Magellan Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010988
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Magellan Diagnostics Inc (Magellan Diagnostics), formerly ESA Inc, a subsidiary of Meridian Bioscience Inc, is a medical device company that provides point-of-care systems, clinical laboratory instruments, and analytical laboratory services. The company’s products include LeadCare II, LeadCare ultra, and LEadCare plus systems. It offers analytical services such as lead and heavy metal exposure, monitoring exposure, and testing services. Magellan Diagnostics also provides education services for clinicians, policy makers, payers, families and communities about permanent health damages caused by lead. The company offers analytical services such as lead and heavy metal exposure, and monitoring exposure. Magellan Diagnostics is headquartered in North Billerica, Massachusetts, the US.

Magellan Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Magellan Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Magellan Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Magellan Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Magellan Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Magellan Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Magellan Diagnostics Inc, Medical Equipment, Deal Details 10
Private Equity 10
Telegraph Hill Partners Acquires Dynex Technologies 10
Partnerships 11
Magellan Diagnostics Enters into Distribution Agreement with Biofirm Technologies 11
Magellan Diagnostics Enters into Distribution Agreement with MedCaptain Medical Technology 12
Biohit Enters Into Distribution Agreement With Dynex Technologies 13
Magellan Biosciences Enters Into An Agreement With Bruker 14
Magellan BioScience Enters Into An Agreement With miacom diagnostics 15
Acquisition 16
Meridian Bioscience Acquires Magellan Diagnostics for USD66 Million 16
Thermo Fisher Scientific Acquires TREK Diagnostic Systems 18
Magellan Diagnostics Inc – Key Competitors 19
Magellan Diagnostics Inc – Key Employees 20
Magellan Diagnostics Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Legal and Regulatory 22
Oct 23, 2017: FDA warns Magellan Diagnostics of significant violations of the law as part of investigation into lead testing issues 22
Oct 23, 2017: Meridian Bioscience Comments on FDA Press Statement Regarding Its Warning Letter Issued to Magellan Diagnostics 23
Government and Public Interest 24
Jun 06, 2017: Meridian Bioscience Comments on Recent FDA Posting Related to Magellan Diagnostics 24
May 17, 2017: FDA warns Americans about risk of inaccurate results from certain lead tests 25
Product News 26
Jan 22, 2016: Instruments to Help Flint Physicians Quickly Test Patients’ Lead Exposure 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Magellan Diagnostics Inc, Medical Equipment, Key Facts 2
Magellan Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Magellan Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Magellan Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Magellan Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Magellan Diagnostics Inc, Deals By Market, 2011 to YTD 2017 8
Magellan Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Telegraph Hill Partners Acquires Dynex Technologies 10
Magellan Diagnostics Enters into Distribution Agreement with Biofirm Technologies 11
Magellan Diagnostics Enters into Distribution Agreement with MedCaptain Medical Technology 12
Biohit Enters Into Distribution Agreement With Dynex Technologies 13
Magellan Biosciences Enters Into An Agreement With Bruker 14
Magellan BioScience Enters Into An Agreement With miacom diagnostics 15
Meridian Bioscience Acquires Magellan Diagnostics for USD66 Million 16
Thermo Fisher Scientific Acquires TREK Diagnostic Systems 18
Magellan Diagnostics Inc, Key Competitors 19
Magellan Diagnostics Inc, Key Employees 20
Magellan Diagnostics Inc, Subsidiaries 21

★海外企業調査レポート[Magellan Diagnostics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • W&T Offshore, Inc. (WTI)-石油・ガス分野:企業M&A・提携分析
    Summary W&T Offshore, Inc. (W&T Offshore) is an independent oil and natural gas company. It carries out acquisition, exploitation, development and exploration of oil and natural gas assets both onshore and offshore in the Gulf of Mexico. The company acquires rights to explore and develop new prospec …
  • Pan Malaysia Holdings Berhad
    Pan Malaysia Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Pan Malaysia Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • ATUM-製薬・医療分野:企業M&A・提携分析
    Summary ATUM, formerly DNA2.0 Inc is a bioengineering company that provide platforms for protein and vector engineering solutions. The company develops and offers synthetic biology solutions. Its products include expression vectors, electra system, CRISPR/Cas9, proteinpaintbox, cell strains and reag …
  • Alarko Holding AS (ALARK):企業の財務・戦略的SWOT分析
    Alarko Holding AS (ALARK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • TechnoPhage SA:製薬・医療:M&Aディール及び事業提携情報
    Summary TechnoPhage SA (TechnoPhage) is a biopharmaceutical company that offers contract research and development of new molecules. The company conducts its research and development of new products based on unique properties of bacteriophages. It also conducts contract research and development servi …
  • A.P. Moller – Maersk AS (MAERSK B)-石油・ガス分野:企業M&A・提携分析
    Summary A.P. Moller - Maersk A/S (APM) is a business conglomerate that carries out operations in global trade, shipping and energy. It operates through a network of tankers, supply ships, container vessels, car carriers, drilling rigs and special vessels. The company also carries out container termi …
  • Drake & Scull International (DSI):企業の財務・戦略的SWOT分析
    Drake & Scull International (DSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • IXYS Corporation (IXYS):企業の財務・戦略的SWOT分析
    IXYS Corporation (IXYS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Pregis LLC.:企業の戦略・SWOT・財務情報
    Pregis LLC. - Strategy, SWOT and Corporate Finance Report Summary Pregis LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Power Finance Corporation Ltd.:企業の戦略・SWOT・財務情報
    Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • RHI AG:戦略・SWOT・企業財務分析
    RHI AG - Strategy, SWOT and Corporate Finance Report Summary RHI AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Co.don AG (CNWK):企業の財務・戦略的SWOT分析
    Summary Co.don AG (Co.don) offers tissue engineering solutions in cultivation and growth of autologous tissue cells for the regenerative treatment of articular cartilage defects and spinal disc defects. The company manufactures and markets autologous, cell-based pharmaceutical products for biologica …
  • Heat Biologics Inc (HTBX)-製薬・医療分野:企業M&A・提携分析
    Summary Heat Biologics Inc (Heat Biologics) is an immuno-oncology company that develops novel therapies to activate patient’s immune system against cancer. The company develops immune pan-antigen cytotoxic therapy, which is a therapeutic vaccine used in the treatment of cancer and infectious disease …
  • KYORIN Holdings Inc (4569):製薬・医療:M&Aディール及び事業提携情報
    Summary KYORIN Holdings Inc (KYORIN), formerly known as KYORIN Co.,Ltd., is a holding company. Its business activities include controlling, administering and supporting companies, which conduct various businesses by holding the shares of those companies. The company through its subsidiaries carries …
  • Protokinetix Inc (PKTX):製薬・医療:M&Aディール及び事業提携情報
    Summary ProtoKinetix Inc (ProtoKinetix) is a biotechnology company that develops solutions for cell survival and health. The company develops anti-aging glycopeptides used to protect cell lines including hela cells, neonatal fibroblasts, adult fibroblast, human neuronal stem cells, CD34+ cells and k …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Metagenics Inc:企業の戦略的SWOT分析
    Metagenics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析
    Summary RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its busine …
  • First Philippine Holdings Corporation:発電所・企業SWOT分析
    First Philippine Holdings Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • China Railway Construction Corporation Ltd:戦略・SWOT・企業財務分析
    China Railway Construction Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Construction Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆